Rob Winn Appointed Director of NCI-Designated Fox Chase Cancer Center
Rob Winn

Rob Winn Appointed Director of NCI-Designated Fox Chase Cancer Center

Fox Chase Cancer Center shared a post on LinkedIn:

“Temple Health – Temple University Health System today announced the appointment of Dr. Rob Winn, MD, as the next Cancer Center Director for Fox Chase Cancer Center, marking a defining moment that will shape the future of one of the nation’s leading National Cancer Institute-designated Comprehensive Cancer Centers.

‘Dr. Winn is the kind of leader who accelerates progress and brings people together to solve the most complex challenges in cancer,’

said Robert Uzzo, MD, MBA, FACS, President and CEO of Fox Chase Cancer Center.

‘With his leadership, Fox Chase is poised to expand its national influence and deliver even greater breakthroughs for patients.’

Winn’s appointment, effective later this summer, underscores Fox Chase’s continued commitment to shaping the future of oncology through groundbreaking cancer research and fostering innovation that advances the standard of care.

Read more.”

Rob Winn, Director at VCU Massey Comprehensive Cancer Center, added:

“I am proud of the work I have been part of over the past several years, and I am thrilled for this new opportunity at Fox Chase Cancer Center.

The level of scientific excellence and progress here is truly inspiring, and I am excited to help advance that science in ways that will have an even greater impact for patients and communities. Fox Chase has a remarkable history, an extraordinary team, and the combined strength of Temple and Fox Chase offers incredible potential to improve cancer research and care not just for Philadelphia, but for the nation.”

Other articles featuring Rob Winn on OncoDaily.